By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Includes articles, courses, and CPGs. Unlimited access for APTA members.
Dec 11, 2025/Policies & Bylaws
BOD Y11-25-04-01: This policy establishes standardized language usage in the development of Association policies, positions, and recommendations to the Board of Directors. It ensures clarity, consistency, and appropriate interpretation of intent and resource implications.
Sep 5, 2025/News
Congress is beginning to formally investigate ongoing issues with the TRICARE system that have affected health care providers and military families who rely on the program for coverage and care.
Feb 4, 2021/Members Only
Topics discussed: FY2022 SNF, IRF, and IPPS rules, VA and HIPAA rules, telehealth update, Info blocking, Wellness Programs, and commercial payer updates.
Podcast
Experts discuss injury prevention concerns, COVID-19 and safe practice and play considerations, and gave recommendations for preparation and implementation of sports activities in the upcoming phases of reopening.
Sep 20, 2019/Policies & Bylaws
House position: APTA supports the following health priorities for populations and individuals in the areas of prevention, wellness, fitness, health promotion, and management of disease and disability.
Mar 31, 2015/CPG
The objective of the guideline is to delineate optimal diagnostic and therapeutic approaches to congenital muscular dystrophy (CMD) through a systematic review and analysis of available literature.
Jul 28, 2015/CPG
Recommendations for the evaluation, diagnosis, prognostication, and treatment of facioscapulohumeral muscular dystrophy (FSHD) from a systematic review and analysis of the evidence.
Apr 15, 2022/Statement
APTA maintains that "physical therapy," whether provided in person or virtually, is performed or directed by licensed physical therapists.
Jul 28, 2025/News
APTA’s new online community offers members a dynamic space for discussion, collaboration, and innovation.
Oct 7, 2022/CPG
Focuses on how pulmonary hypertension (PH) may involve multiple clinical conditions and pose complications for the majority of cardiovascular and respiratory diseases.